» Articles » PMID: 26833167

A Multicenter Study in Mexico Finds Acinetobacter Baumannii Clinical Isolates Belonging to Clonal Complexes 636B (113B) and 92B Harboring OXA-72, OXA-239, and OXA-469

Citing Articles

Intrahospital dissemination of multidrug-resistant at a teaching hospital in Northeast of Mexico.

Villarreal-Cruz S, Camacho-Ortiz A, Flores-Trevino S, Villarreal-Trevino L, Bocanegra-Ibarias P Infect Prev Pract. 2025; 7(1):100443.

PMID: 39995978 PMC: 11849607. DOI: 10.1016/j.infpip.2025.100443.


Blue benzoquinone from scorpion venom shows bactericidal activity against drug-resistant strains of the priority pathogen Acinetobacter baumannii.

Gallegos-Monterrosa R, Cid-Uribe J, Delgado-Prudencio G, Perez-Morales D, Banda M, Tellez-Galvan A J Antibiot (Tokyo). 2025; .

PMID: 39966632 DOI: 10.1038/s41429-025-00809-8.


Genomic analysis of the main epidemiological lineages of in Mexico.

Humberto B, Luis L, Josefina D Front Cell Infect Microbiol. 2025; 14:1499839.

PMID: 39867342 PMC: 11757933. DOI: 10.3389/fcimb.2024.1499839.


IC2 and IC5 Isolates with Co-Existing and and Exhibiting Strong Biofilm Formation in a Mexican Hospital.

Moreno-Manjon J, Castillo-Ramirez S, Jolley K, Maiden M, Gayosso-Vazquez C, Fernandez-Vazquez J Microorganisms. 2023; 11(9).

PMID: 37764160 PMC: 10536109. DOI: 10.3390/microorganisms11092316.


Molecular Epidemiology of - Complex Isolated From Children at the Hospital Infantil de México Federico Gómez.

Mancilla-Rojano J, Ochoa S, Reyes-Grajeda J, Flores V, Medina-Contreras O, Espinosa-Mazariego K Front Microbiol. 2020; 11:576673.

PMID: 33178158 PMC: 7593844. DOI: 10.3389/fmicb.2020.576673.


References
1.
Morfin-Otero R, Alcantar-Curiel M, Rocha M, Alpuche-Aranda C, Santos-Preciado J, Gayosso-Vazquez C . Acinetobacter baumannii infections in a tertiary care hospital in Mexico over the past 13 years. Chemotherapy. 2013; 59(1):57-65. DOI: 10.1159/000351098. View

2.
Gundi V, Dijkshoorn L, Burignat S, Raoult D, La Scola B . Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology (Reading). 2009; 155(Pt 7):2333-2341. DOI: 10.1099/mic.0.026054-0. View

3.
Bocanegra-Ibarias P, Pena-Lopez C, Camacho-Ortiz A, Llaca-Diaz J, Silva-Sanchez J, Barrios H . Genetic characterisation of drug resistance and clonal dynamics of Acinetobacter baumannii in a hospital setting in Mexico. Int J Antimicrob Agents. 2015; 45(3):309-13. DOI: 10.1016/j.ijantimicag.2014.10.022. View

4.
Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D . Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol. 2005; 43(9):4328-35. PMC: 1234071. DOI: 10.1128/JCM.43.9.4328-4335.2005. View

5.
Dortet L, Poirel L, Errera C, Nordmann P . CarbAcineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp. J Clin Microbiol. 2014; 52(7):2359-64. PMC: 4097681. DOI: 10.1128/JCM.00594-14. View